Skip to main navigation
Skip to search
Skip to main content
Experts@Minnesota Home
Home
Profiles
Research units
University Assets
Projects and Grants
Research output
Datasets
Press/Media
Activities
Fellowships, Honors, and Prizes
Impacts
Search by expertise, name or affiliation
Treatment of ANCA-associated vasculitis: New therapies and a look at old entities
Ladan Zand
, Ulrich Specks
, Sanjeev Sethi
, Fernando C. Fervenza
Research output
:
Contribution to journal
›
Review article
›
peer-review
7
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Treatment of ANCA-associated vasculitis: New therapies and a look at old entities'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
New Therapies
100%
Antineutrophil Cytoplasmic Antibody-associated Vasculitis
100%
ANCA-associated Vasculitis
100%
Rituximab
50%
Cyclophosphamide
50%
Treatment Choice
25%
Remission Induction
25%
Induction Therapy
25%
Maintenance Therapy
25%
Newly Diagnosed
25%
Clinical Syndromes
25%
Granulomatosis with Polyangiitis
25%
Large Vessel Vasculitis
25%
Microscopic Polyangiitis
25%
Immunology and Microbiology
ANCA Associated Vasculitis
100%
Rituximab
33%
Cyclophosphamide
33%
Microscopic Polyangiitis
16%
Vasculitis
16%
Granulomatosis with Polyangiitis
16%
Glucocorticoid
16%